- Home
- NAGE vs AGL Comparison
NAGE vs AGL Comparison
Compare NAGE & AGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAGE
- AGL
- Stock Information
- Founded
- NAGE 1999
- AGL 2016
- Country
- NAGE United States
- AGL United States
- Employees
- NAGE N/A
- AGL N/A
- Industry
- NAGE Medicinal Chemicals and Botanical Products
- AGL Managed Health Care
- Sector
- NAGE Health Care
- AGL Health Care
- Exchange
- NAGE Nasdaq
- AGL Nasdaq
- Market Cap
- NAGE 861.0M
- AGL 968.6M
- IPO Year
- NAGE N/A
- AGL 2021
- Fundamental
- Price
- NAGE $11.73
- AGL $2.25
- Analyst Decision
- NAGE Strong Buy
- AGL Hold
- Analyst Count
- NAGE 2
- AGL 20
- Target Price
- NAGE $12.00
- AGL $4.47
- AVG Volume (30 Days)
- NAGE 1.2M
- AGL 5.1M
- Earning Date
- NAGE 05-07-2025
- AGL 05-06-2025
- Dividend Yield
- NAGE N/A
- AGL N/A
- EPS Growth
- NAGE N/A
- AGL N/A
- EPS
- NAGE 0.18
- AGL N/A
- Revenue
- NAGE $107,925,000.00
- AGL $5,988,958,000.00
- Revenue This Year
- NAGE $25.46
- AGL N/A
- Revenue Next Year
- NAGE $21.72
- AGL $9.89
- P/E Ratio
- NAGE $65.43
- AGL N/A
- Revenue Growth
- NAGE 29.77
- AGL 23.07
- 52 Week Low
- NAGE $2.31
- AGL $1.50
- 52 Week High
- NAGE $11.79
- AGL $7.73
- Technical
- Relative Strength Index (RSI)
- NAGE N/A
- AGL 32.60
- Support Level
- NAGE N/A
- AGL $2.17
- Resistance Level
- NAGE N/A
- AGL $2.38
- Average True Range (ATR)
- NAGE 0.00
- AGL 0.17
- MACD
- NAGE 0.00
- AGL 0.01
- Stochastic Oscillator
- NAGE 0.00
- AGL 11.50
About NAGE Niagen Bioscience Inc. Common Stock
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
About AGL agilon health inc.
Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.